Drug intelligence / Profile preview

carboxymethylated β-glucan

Development stage
Phase 4
Lead developer
Mibelle AG
Administration
Oral, Topical, Subcutaneous
01

Overview

Carboxymethylated β-glucan is a chemically modified, water-soluble derivative of β(1→3)(1→6) glucan, typically sourced from yeast (e.g., Saccharomyces species). This compound demonstrates antioxidant, immunomodulatory, anti-inflammatory, and wound-healing properties. As a derivative of β-glucan, it is more soluble and bioavailable, facilitating oral and topical applications. Carboxymethylated β-glucan has been studied for its ability to reduce oxidative stress (e.g., lowering malondialdehyde), promote immune responses, modulate macrophage activity, and accelerate wound healing. It is also investigated as a component of nanocarriers for antigen delivery and as a sprayable hydrogel for enhancing tissue regeneration and healing, particularly in diabetic models. Its mechanism involves modulation of the innate immune system and antioxidant pathways, though no unique molecular target has been specifically identified[1][2][3].

Brand names
Colpofix
Other names
carboxymethylated β-glucancarboxymethyl-glucanCM-Gcarboxymethyl-β-glucanCMβGcarboxymethylated yeast β-glucan
02

Targets

CLEC7A (Dectin-1)

Beyond the preview

Go deeper on carboxymethylated β-glucan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carboxymethylated β-glucan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call